🔎 Trials Near Me

Utama › Keadaan Pasca-COVID (Long COVID) › Virginia

Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Virginia

6 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Virginia.

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Charlottesville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Velocity Clinical Research, Suffolk, Suffolk
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

  • Velocity Clinical Research - Hampton ( Site 3744), Hampton
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06667700

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

  • GSK Investigational Site, Charlottesville
  • GSK Investigational Site, Newport News
Mengambil pesertaFasa 1
Umur 65 hingga 85 · Semua jantina · Dikemas kini 30 Jun 2026 · NCT07464314

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

  • VCU Health System, Richmond
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 23 Jun 2026 · NCT03808922

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

  • Richard Bennett - Clinical Research Partners, Richmond
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
6 Months · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06585241

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.